H.C. Wainwright Reiterates Buy Rating on Olema Pharmaceuticals (OLMA)
Tweet Send to a Friend
(Updated - May 29, 2025 6:59 AM EDT)
H.C. Wainwright analyst Emily Bodnar reiterated a Buy rating and $28.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
H.C. Wainwright analyst Emily Bodnar reiterated a Buy rating and $28.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
